Methotrexate and Tumor Necrosis Factor Inhibitors Independently Decrease Neutralizing Antibodies after SARS-CoV-2 Vaccination: Updated Results from the SUCCEED Study

<b>Objective:</b> SARS-CoV-2 remains the third most common cause of death in North America. We studied the effects of methotrexate and tumor necrosis factor inhibitor (TNFi) on neutralization responses after COVID-19 vaccination in immune-mediated inflammatory disease (IMID). <b>Methods:</b> Prospec...

Повний опис

Бібліографічні деталі

Автори:	Carol A Hitchon, Dawn M. E. Bowdish, Gilles Boire, Paul R. Fortin, Louis Flamand, Vinod Chandran, Roya M. Dayam, Anne-Claude Gingras, Catherine M. Card, Inés Colmegna, Maggie J. Larché, Gilaad G. Kaplan, Luck Lukusa, Jennifer L.F. Lee, Sasha Bernatsky, on behalf of the SUCCEED Investigative Team
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2024-09-01
Серія:	Vaccines
Предмети:	COVID-19 vaccination immune-mediated inflammatory disease methotrexate tumor necrosis factor inhibitors autoimmune diseases
Онлайн доступ:	https://www.mdpi.com/2076-393X/12/9/1061
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!